Andrew Robbins
Vorstandsvorsitzender bei COGENT BIOSCIENCES, INC.
Vermögen: - $ am 30.04.2024
Profil
Andrew R.
Robbins is currently the President, Chief Executive Officer & Director at Cogent Biosciences, Inc. and an Independent Director at Turmeric Acquisition Corp.
He previously served as a Director at Cytograft Tissue Engineering, Inc., StemCor Systems, Inc., and Fate Therapeutics, Inc. From 2020 to 2024, he was an Independent Director at Harpoon Therapeutics, Inc. Prior to that, he was the Chief Operating Officer at Array BioPharma, Inc. from 2015 to 2019.
He also held the position of General Manager & Vice President at Hospira, Inc. from 2007 to 2012 and Senior Vice President-Commercial Operations at Pfizer Inc. from 2012 to 2015.
Mr. Robbins completed his undergraduate degree at Swarthmore College and holds an MBA from Kellogg School of Management.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
COGENT BIOSCIENCES, INC.
-.--% | 19.03.2024 | 0 ( -.--% ) | - $ | 30.04.2024 |
Aktive Positionen von Andrew Robbins
| Unternehmen | Position | Beginn |
|---|---|---|
| TURMERIC ACQUISITION CORP. | Direktor/Vorstandsmitglied | 01.10.2020 |
| COGENT BIOSCIENCES, INC. | Vorstandsvorsitzender | 23.10.2020 |
Ehemalige bekannte Positionen von Andrew Robbins
| Unternehmen | Position | Ende |
|---|---|---|
| HARPOON THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 11.03.2024 |
| ARRAY TECHNOLOGIES, INC. | Geschäftsführer | 01.01.2019 |
| PFIZER, INC. | Geschäftsführer | 01.03.2015 |
| HOSPIRA, INC. | Corporate Officer/Principal | 01.07.2012 |
StemCor Systems, Inc.
 StemCor Systems, Inc. Medical SpecialtiesHealth Technology StemCor Systems, Inc. develops proprietary and minimally-invasive bone marrow collection systems for regenerative medicine. Its products include MarrowMiner System and MarrowSelect. The company was founded in June 2003 by Daniel Kraft and is headquartered in Menlo Park, CA. | Direktor/Vorstandsmitglied | - |
Ausbildung von Andrew Robbins
| Swarthmore College | Undergraduate Degree |
| Kellogg School of Management | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| FATE THERAPEUTICS, INC. | Health Technology |
| COGENT BIOSCIENCES, INC. | Health Technology |
| PFIZER, INC. | Health Technology |
| Private Unternehmen | 6 |
|---|---|
Array BioPharma, Inc.
 Array BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Array BioPharma, Inc. is a biopharmaceutical company. Its focus is on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer and other high-burden diseases. The company's products are BRAFTOVI and MEKTOVI. Its portfolio includes Binimetinib, Selumetinib, Encorafenib, Filanesib, Ipatasertib, Varltinib, Danoprevir, ARRY-797, Larotrectinib, Tucatinib, ARRY-382, Motolimod, Prexasertib, GDC-0575, LOXO-292, LOXO-195, and AK-1830. The company was founded by Kevin Koch, Anthony D. Piscopio, K. C. Nicolaou, and David L. Snitman in 1998 and is headquartered in Boulder, CO. | Health Technology |
Hospira, Inc.
 Hospira, Inc. Pharmaceuticals: MajorHealth Technology Hospira, Inc. provides injectable drugs and infusion technologies. It offers drugs, IV sets and clinical integration, infusion pumps, clinical software and implementation services. The company was founded on September 16, 2003 and is headquartered in Lake Forest, IL. | Health Technology |
Cytograft Tissue Engineering, Inc.
 Cytograft Tissue Engineering, Inc. Pharmaceuticals: MajorHealth Technology Cytograft Tissue Engineering, Inc. engages in the development of cardiovascular medicine. It offers novel cell-based therapies to repair and rebuild diseased tissues and organ without using synthetic biomaterials. The company was founded by Todd N. McAllister and Nicolas L'Heureux in 2000 and is headquartered in Novato, CA. | Health Technology |
StemCor Systems, Inc.
StemCor Systems, Inc. Medical SpecialtiesHealth Technology StemCor Systems, Inc. develops proprietary and minimally-invasive bone marrow collection systems for regenerative medicine. Its products include MarrowMiner System and MarrowSelect. The company was founded in June 2003 by Daniel Kraft and is headquartered in Menlo Park, CA. | Health Technology |
Harpoon Therapeutics, Inc.
 Harpoon Therapeutics, Inc. BiotechnologyHealth Technology Harpoon Therapeutics, Inc. is a clinical-stage immunotherapy company, which engages in the development of antibodies. It focuses on the research of novel class of T cell engagers that harness the power of the body’s immune system to treat patients suffering from cancer and other diseases. The firm utilizes its proprietary Tri-specific T cell Activating Construct platform to create a pipeline of novel TriTACs for the treatment of solid tumors and hematologic malignancies. The company was founded by Patrick A. Baeuerle, Luke B. Evnin, and Jeanmarie Guenot on March 19, 2015 and is headquartered in South San Francisco, CA. | Health Technology |
Turmeric Acquisition Corp.
 Turmeric Acquisition Corp. Financial ConglomeratesFinance Turmeric Acquisition Corp. operates as a blank check company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on August 28, 2020 and is headquartered in Cambridge, MA. | Finance |
